Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

NCT03367871 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Investigator left institution

Conditions

Cervical Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Bevacizumab

Sponsor

University of Miami

Collaborators

[object Object]